Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Part of paid clinical trials in Oxnard, California.

Sponsor
Geriatric Oncology Consortium
Study ID
NCT00120198
Phase
PHASE2
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Currently there is no one standard of care for older patients with Non-Hodgkin's Lymphoma (NHL). The study will examine the tolerability and feasibility to the combination of Cyclophosphamide, Pegylated Liposomal Doxorubicin, Vincristine, Prednisone (CDOP) plus Rituximab.

Key Dates

Start date
Mar 31, 2005
Status verified
Nov 2007
Completion
Sep 30, 2006

Study Design

Enrollment
50 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

To evaluate the feasibility and tolerability of CDOP plus rituximab in elderly patients with previously untreated NHL.

Locations (5)

FacilityCityStateZIPSite coordinators
-OxnardCalifornia93030-
-Washington D.C.District of Columbia20007-
-InvernessFlorida34452-
-LecantoFlorida34461-
-BellevilleNew Jersey07109-

Related Studies